Cargando…
Correction: Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8975942/ https://www.ncbi.nlm.nih.gov/pubmed/35365596 http://dx.doi.org/10.1038/s41392-022-00958-4 |
| _version_ | 1784680466340642816 |
|---|---|
| author | Zhang, Qi Riley-Gillis, Bridget Han, Lina Jia, Yannan Lodi, Alessia Zhang, Haijiao Ganesan, Saravanan Pan, Rongqing Konoplev, Sergej N. Sweeney, Shannon R. Ryan, Jeremy A. Jitkova, Yulia Dunner, Kenneth Grosskurth, Shaun E. Vijay, Priyanka Ghosh, Sujana Lu, Charles Ma, Wencai Kurtz, Stephen Ruvolo, Vivian R. Ma, Helen Weng, Connie C. Ramage, Cassandra L. Baran, Natalia Shi, Ce Cai, Tianyu Davis, Richard Eric Battula, Venkata L. Mi, Yingchang Wang, Jing DiNardo, Courtney D. Andreeff, Michael Tyner, Jeffery W. Schimmer, Aaron Letai, Anthony Padua, Rose Ann Bueso-Ramos, Carlos E. Tiziani, Stefano Leverson, Joel Popovic, Relja Konopleva, Marina |
| author_facet | Zhang, Qi Riley-Gillis, Bridget Han, Lina Jia, Yannan Lodi, Alessia Zhang, Haijiao Ganesan, Saravanan Pan, Rongqing Konoplev, Sergej N. Sweeney, Shannon R. Ryan, Jeremy A. Jitkova, Yulia Dunner, Kenneth Grosskurth, Shaun E. Vijay, Priyanka Ghosh, Sujana Lu, Charles Ma, Wencai Kurtz, Stephen Ruvolo, Vivian R. Ma, Helen Weng, Connie C. Ramage, Cassandra L. Baran, Natalia Shi, Ce Cai, Tianyu Davis, Richard Eric Battula, Venkata L. Mi, Yingchang Wang, Jing DiNardo, Courtney D. Andreeff, Michael Tyner, Jeffery W. Schimmer, Aaron Letai, Anthony Padua, Rose Ann Bueso-Ramos, Carlos E. Tiziani, Stefano Leverson, Joel Popovic, Relja Konopleva, Marina |
| author_sort | Zhang, Qi |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8975942 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-89759422022-04-20 Correction: Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia Zhang, Qi Riley-Gillis, Bridget Han, Lina Jia, Yannan Lodi, Alessia Zhang, Haijiao Ganesan, Saravanan Pan, Rongqing Konoplev, Sergej N. Sweeney, Shannon R. Ryan, Jeremy A. Jitkova, Yulia Dunner, Kenneth Grosskurth, Shaun E. Vijay, Priyanka Ghosh, Sujana Lu, Charles Ma, Wencai Kurtz, Stephen Ruvolo, Vivian R. Ma, Helen Weng, Connie C. Ramage, Cassandra L. Baran, Natalia Shi, Ce Cai, Tianyu Davis, Richard Eric Battula, Venkata L. Mi, Yingchang Wang, Jing DiNardo, Courtney D. Andreeff, Michael Tyner, Jeffery W. Schimmer, Aaron Letai, Anthony Padua, Rose Ann Bueso-Ramos, Carlos E. Tiziani, Stefano Leverson, Joel Popovic, Relja Konopleva, Marina Signal Transduct Target Ther Correction Nature Publishing Group UK 2022-04-01 /pmc/articles/PMC8975942/ /pubmed/35365596 http://dx.doi.org/10.1038/s41392-022-00958-4 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correction Zhang, Qi Riley-Gillis, Bridget Han, Lina Jia, Yannan Lodi, Alessia Zhang, Haijiao Ganesan, Saravanan Pan, Rongqing Konoplev, Sergej N. Sweeney, Shannon R. Ryan, Jeremy A. Jitkova, Yulia Dunner, Kenneth Grosskurth, Shaun E. Vijay, Priyanka Ghosh, Sujana Lu, Charles Ma, Wencai Kurtz, Stephen Ruvolo, Vivian R. Ma, Helen Weng, Connie C. Ramage, Cassandra L. Baran, Natalia Shi, Ce Cai, Tianyu Davis, Richard Eric Battula, Venkata L. Mi, Yingchang Wang, Jing DiNardo, Courtney D. Andreeff, Michael Tyner, Jeffery W. Schimmer, Aaron Letai, Anthony Padua, Rose Ann Bueso-Ramos, Carlos E. Tiziani, Stefano Leverson, Joel Popovic, Relja Konopleva, Marina Correction: Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia |
| title | Correction: Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia |
| title_full | Correction: Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia |
| title_fullStr | Correction: Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia |
| title_full_unstemmed | Correction: Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia |
| title_short | Correction: Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia |
| title_sort | correction: activation of ras/mapk pathway confers mcl-1 mediated acquired resistance to bcl-2 inhibitor venetoclax in acute myeloid leukemia |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8975942/ https://www.ncbi.nlm.nih.gov/pubmed/35365596 http://dx.doi.org/10.1038/s41392-022-00958-4 |
| work_keys_str_mv | AT zhangqi correctionactivationofrasmapkpathwayconfersmcl1mediatedacquiredresistancetobcl2inhibitorvenetoclaxinacutemyeloidleukemia AT rileygillisbridget correctionactivationofrasmapkpathwayconfersmcl1mediatedacquiredresistancetobcl2inhibitorvenetoclaxinacutemyeloidleukemia AT hanlina correctionactivationofrasmapkpathwayconfersmcl1mediatedacquiredresistancetobcl2inhibitorvenetoclaxinacutemyeloidleukemia AT jiayannan correctionactivationofrasmapkpathwayconfersmcl1mediatedacquiredresistancetobcl2inhibitorvenetoclaxinacutemyeloidleukemia AT lodialessia correctionactivationofrasmapkpathwayconfersmcl1mediatedacquiredresistancetobcl2inhibitorvenetoclaxinacutemyeloidleukemia AT zhanghaijiao correctionactivationofrasmapkpathwayconfersmcl1mediatedacquiredresistancetobcl2inhibitorvenetoclaxinacutemyeloidleukemia AT ganesansaravanan correctionactivationofrasmapkpathwayconfersmcl1mediatedacquiredresistancetobcl2inhibitorvenetoclaxinacutemyeloidleukemia AT panrongqing correctionactivationofrasmapkpathwayconfersmcl1mediatedacquiredresistancetobcl2inhibitorvenetoclaxinacutemyeloidleukemia AT konoplevsergejn correctionactivationofrasmapkpathwayconfersmcl1mediatedacquiredresistancetobcl2inhibitorvenetoclaxinacutemyeloidleukemia AT sweeneyshannonr correctionactivationofrasmapkpathwayconfersmcl1mediatedacquiredresistancetobcl2inhibitorvenetoclaxinacutemyeloidleukemia AT ryanjeremya correctionactivationofrasmapkpathwayconfersmcl1mediatedacquiredresistancetobcl2inhibitorvenetoclaxinacutemyeloidleukemia AT jitkovayulia correctionactivationofrasmapkpathwayconfersmcl1mediatedacquiredresistancetobcl2inhibitorvenetoclaxinacutemyeloidleukemia AT dunnerkenneth correctionactivationofrasmapkpathwayconfersmcl1mediatedacquiredresistancetobcl2inhibitorvenetoclaxinacutemyeloidleukemia AT grosskurthshaune correctionactivationofrasmapkpathwayconfersmcl1mediatedacquiredresistancetobcl2inhibitorvenetoclaxinacutemyeloidleukemia AT vijaypriyanka correctionactivationofrasmapkpathwayconfersmcl1mediatedacquiredresistancetobcl2inhibitorvenetoclaxinacutemyeloidleukemia AT ghoshsujana correctionactivationofrasmapkpathwayconfersmcl1mediatedacquiredresistancetobcl2inhibitorvenetoclaxinacutemyeloidleukemia AT lucharles correctionactivationofrasmapkpathwayconfersmcl1mediatedacquiredresistancetobcl2inhibitorvenetoclaxinacutemyeloidleukemia AT mawencai correctionactivationofrasmapkpathwayconfersmcl1mediatedacquiredresistancetobcl2inhibitorvenetoclaxinacutemyeloidleukemia AT kurtzstephen correctionactivationofrasmapkpathwayconfersmcl1mediatedacquiredresistancetobcl2inhibitorvenetoclaxinacutemyeloidleukemia AT ruvolovivianr correctionactivationofrasmapkpathwayconfersmcl1mediatedacquiredresistancetobcl2inhibitorvenetoclaxinacutemyeloidleukemia AT mahelen correctionactivationofrasmapkpathwayconfersmcl1mediatedacquiredresistancetobcl2inhibitorvenetoclaxinacutemyeloidleukemia AT wengconniec correctionactivationofrasmapkpathwayconfersmcl1mediatedacquiredresistancetobcl2inhibitorvenetoclaxinacutemyeloidleukemia AT ramagecassandral correctionactivationofrasmapkpathwayconfersmcl1mediatedacquiredresistancetobcl2inhibitorvenetoclaxinacutemyeloidleukemia AT barannatalia correctionactivationofrasmapkpathwayconfersmcl1mediatedacquiredresistancetobcl2inhibitorvenetoclaxinacutemyeloidleukemia AT shice correctionactivationofrasmapkpathwayconfersmcl1mediatedacquiredresistancetobcl2inhibitorvenetoclaxinacutemyeloidleukemia AT caitianyu correctionactivationofrasmapkpathwayconfersmcl1mediatedacquiredresistancetobcl2inhibitorvenetoclaxinacutemyeloidleukemia AT davisricharderic correctionactivationofrasmapkpathwayconfersmcl1mediatedacquiredresistancetobcl2inhibitorvenetoclaxinacutemyeloidleukemia AT battulavenkatal correctionactivationofrasmapkpathwayconfersmcl1mediatedacquiredresistancetobcl2inhibitorvenetoclaxinacutemyeloidleukemia AT miyingchang correctionactivationofrasmapkpathwayconfersmcl1mediatedacquiredresistancetobcl2inhibitorvenetoclaxinacutemyeloidleukemia AT wangjing correctionactivationofrasmapkpathwayconfersmcl1mediatedacquiredresistancetobcl2inhibitorvenetoclaxinacutemyeloidleukemia AT dinardocourtneyd correctionactivationofrasmapkpathwayconfersmcl1mediatedacquiredresistancetobcl2inhibitorvenetoclaxinacutemyeloidleukemia AT andreeffmichael correctionactivationofrasmapkpathwayconfersmcl1mediatedacquiredresistancetobcl2inhibitorvenetoclaxinacutemyeloidleukemia AT tynerjefferyw correctionactivationofrasmapkpathwayconfersmcl1mediatedacquiredresistancetobcl2inhibitorvenetoclaxinacutemyeloidleukemia AT schimmeraaron correctionactivationofrasmapkpathwayconfersmcl1mediatedacquiredresistancetobcl2inhibitorvenetoclaxinacutemyeloidleukemia AT letaianthony correctionactivationofrasmapkpathwayconfersmcl1mediatedacquiredresistancetobcl2inhibitorvenetoclaxinacutemyeloidleukemia AT paduaroseann correctionactivationofrasmapkpathwayconfersmcl1mediatedacquiredresistancetobcl2inhibitorvenetoclaxinacutemyeloidleukemia AT buesoramoscarlose correctionactivationofrasmapkpathwayconfersmcl1mediatedacquiredresistancetobcl2inhibitorvenetoclaxinacutemyeloidleukemia AT tizianistefano correctionactivationofrasmapkpathwayconfersmcl1mediatedacquiredresistancetobcl2inhibitorvenetoclaxinacutemyeloidleukemia AT leversonjoel correctionactivationofrasmapkpathwayconfersmcl1mediatedacquiredresistancetobcl2inhibitorvenetoclaxinacutemyeloidleukemia AT popovicrelja correctionactivationofrasmapkpathwayconfersmcl1mediatedacquiredresistancetobcl2inhibitorvenetoclaxinacutemyeloidleukemia AT konoplevamarina correctionactivationofrasmapkpathwayconfersmcl1mediatedacquiredresistancetobcl2inhibitorvenetoclaxinacutemyeloidleukemia |